Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity ; volume:21 ; number:1 ; day:2 ; month:7 ; year:2024 ; pages:1-12 ; date:12.2024
Virology journal ; 21, Heft 1 (2.7.2024), 1-12, 12.2024
- Creator
-
AlQahtani, Hajar Y.
AlSuhebany, Nada
Alowais, Shuroug A.
AlShehri, Bashayer
Althemery, Abdullah
Alghanim, Amirah
Alqahtani, Hessa
Alkhathran, Lama
Alyaqub, Majd
Alsulimani, Mariam
AlHarbi, Ahmad
Alhatmi, Hind
Almansour, Sarah
Almohaya, Abdulellah
Bosaeed, Mohammed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02421-y
- URN
-
urn:nbn:de:101:1-2409202106277.620121342985
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- AlQahtani, Hajar Y.
- AlSuhebany, Nada
- Alowais, Shuroug A.
- AlShehri, Bashayer
- Althemery, Abdullah
- Alghanim, Amirah
- Alqahtani, Hessa
- Alkhathran, Lama
- Alyaqub, Majd
- Alsulimani, Mariam
- AlHarbi, Ahmad
- Alhatmi, Hind
- Almansour, Sarah
- Almohaya, Abdulellah
- Bosaeed, Mohammed
- SpringerLink (Online service)
Other Objects (12)
Fetal Cytomegalovirus Infection in the Absence of Maternal Cytomegalovirus-IgM Seropositivity
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"
Comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Molecular and cellular determinants for effective cytomegalovirus immunity after allogeneic stem cell transplantation
Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases
Response to comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
Immune response against human cytomegalovirus in the context of hematopoietic stem cell transplantation (HSCT)
Lentivirus-induced dendritic cells as cellular vaccine against cytomegalovirus infection after hematopoietic stem cell transplantation
Fetal Cytomegalovirus Infection in the Absence of Maternal Cytomegalovirus-IgM Seropositivity
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"
Comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Molecular and cellular determinants for effective cytomegalovirus immunity after allogeneic stem cell transplantation
Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases
Response to comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
Immune response against human cytomegalovirus in the context of hematopoietic stem cell transplantation (HSCT)
Lentivirus-induced dendritic cells as cellular vaccine against cytomegalovirus infection after hematopoietic stem cell transplantation
Fetal Cytomegalovirus Infection in the Absence of Maternal Cytomegalovirus-IgM Seropositivity
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Comment to "Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis"
Comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Molecular and cellular determinants for effective cytomegalovirus immunity after allogeneic stem cell transplantation
Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases
Response to comment on human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
Immune response against human cytomegalovirus in the context of hematopoietic stem cell transplantation (HSCT)